Status:
COMPLETED
Bioequivalence Study in Healthy Volunteers
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG).
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00387985
Start Date
August 1 2006
End Date
September 1 2006
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Willingboro, New Jersey, United States, 08046